Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1(2-butyl-5-nitrobenzofuran-3-yl)(4-hydroxyphenyl)methanone

02 1(2S)-1-(Chloroacetyl)-2-pyrrolidinecarbonitrile

03 1(2Z)-4-Oxo-4-[3-(trifluoromethyl)-5,6-dihhyrdro[1,2,4] triazolo [4,3-a] pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl) butan-2-one

04 1(3R,4R)-1-Benzyl-N,4-dimethyl-3-piperidinamine dihydrochloride

05 11-(2-Chloroethyl)-piperidine hydrochloride

06 11-(2-Ethoxy-ethyl)-2-piperidin-4-yl-1H-benzimidazole

07 11-(2-Ethoxy-ethyl)-2-piperidin-4-yl-1H-benzimidazole Hydrochloride

08 11-(3-Pyridyl)-3-(dimethylamino)-2-propen-1-one

09 11-(3-iodo-1-isopropyl-1H-pyrazol-4-yl)ethanone

10 11-chloro-4-methoxybutane

11 12,3-Dibromobutane-1,4-diol

12 12-(2-Ethoxyphenoxy)ethyl Methanesulfonate

13 12-(2-Ethoxyphenoxy)ethyl bromide

14 12-(4-Bromo-phenyl)-2-methyl-propionic acid

15 12-(piperidin-4-yl)-1H-benzo[d]imidazole

16 12-Chloro-5-hydroxypyridine

17 12-[2-(2,2,2-Trifluoroethoxy)phenoxy]ethyl methanesulfonate

18 12-[4-(2-chloro-ethyl)-phenyl]-2-methyl-propionic acid methyl ester

19 12-[4-[1-(4,4-dimethyl-5H-oxazol-2yl)-1-methyl-ethyl]phenyl]ethyl 4-methylbenzenesulfonate

20 12-allyl-3-methoxybenzaldehyde

21 12-butyl-3-[4-(3-dibutylaminopropoxy)benzoyl]-5-nitrobenzofura

22 12-ethoxyethyl-4-methylbenzenesulfonate

23 12-n-Butyl-5-nitrobenzofuran

24 13'-Bromoacetophenone

25 13,5-Dichloro salicylaldehyde

26 13-(2-Chloroethyl)-6,7,8,9-tetrahydro-9-hydroxy-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one

27 13-Acetylpyridine

28 13-Amino-4-methylpyridine

29 13-Methylflavone -8-Carboxylic Acid

30 13-amino-1-Adamantanol

31 14-((4-methylpiperazin-1-yl)methyl)benzoic acid dihydrochloride

32 14-(1-Hydroxy-1-methylethyl)-2-propyl-1H-imidazole-5-carboxylic Acid Ethyl Ester)

33 14-(trifluoromethyl)benzonitrile

34 14-Bromopyridine hydrochloride

35 14-Methyl-3-[4-(3-pyridyl)pyrimidin-2-ylamino]aniline

36 14-Nitropyrazole

37 15-Amino-2-chloropyridine

38 15-Amino-4,6-dichloro-2-(propylthio)pyrimidine

39 15-Methoxy-1-[4-(trifluoromethyl)phenyl]-1-pentanone

40 25-Nitrosalicylaldehyde

41 15-[(2R)-2-Aminopropyl]-1-[3-(benzoyloxy)propyl]-2,3-dihydro-1H-indole-7-carbonitrile (2R,3R)-2,3-dihydroxybutanedioate

42 15-[(2R)-2-Aminopropyl]-2,3-dihydro-1-[3-(phenylmethoxy)propyl]-1H-indole-7-carbonitrile

43 1Bromoacetaldehyde diethyl acetal

44 1Butadiene diepoxide

45 1Chloro-7H-pyrrolo[2,3-d]pyrimidine

46 1R-(-)-5-(2-Amino-propyl)-2-methoxy-benzenesulfonamide

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass
141645-16-1
Ocimum Labs was founded in 2018 and started its R&D activities with a cutting-edge facility. The Hyd...
Ocimum Labs was founded in 2018 and started its R&D activities with a cutting-edge facility. The Hyderabad-based firm focuses on process research and development, with a particular emphasis on choosing an API portfolio with a wide range of applications for the global pharma market. It provides a wide variety of integrated products and services. By offering timely and high-quality support, Ocimum Labs hopes to become a strategic partner to global pharma firms and deliver high-quality, cost effective key starting materials, intermediates and APIs. It intends to build a manufacturing facility with a 230KL capacity in Visakhapatnam, India.
blank
207557-35-5
Vildagliptin
Ocimum Labs was founded in 2018 and started its R&D activities with a cutting-edge facility. The Hyd...
Ocimum Labs was founded in 2018 and started its R&D activities with a cutting-edge facility. The Hyderabad-based firm focuses on process research and development, with a particular emphasis on choosing an API portfolio with a wide range of applications for the global pharma market. It provides a wide variety of integrated products and services. By offering timely and high-quality support, Ocimum Labs hopes to become a strategic partner to global pharma firms and deliver high-quality, cost effective key starting materials, intermediates and APIs. It intends to build a manufacturing facility with a 230KL capacity in Visakhapatnam, India.
blank

02

Fi Europe 2024
Not Confirmed
arrow
Fi Europe 2024
Not Confirmed
arrow

Ocimum Labs

(2S)-1-(Chloroacetyl)-2-pyrrolidinecarbonitrile

CAS Number : 207557-35-5

End Use API : Vildagliptin

About the Company : Ocimum Labs was founded in 2018 and started its R&D activities with a cutting-edge facility. The Hyderabad-based firm fo...

blank
764667-65-4
Sitagliptin Phosphate
Ocimum Labs was founded in 2018 and started its R&D activities with a cutting-edge facility. The Hyd...
Ocimum Labs was founded in 2018 and started its R&D activities with a cutting-edge facility. The Hyderabad-based firm focuses on process research and development, with a particular emphasis on choosing an API portfolio with a wide range of applications for the global pharma market. It provides a wide variety of integrated products and services. By offering timely and high-quality support, Ocimum Labs hopes to become a strategic partner to global pharma firms and deliver high-quality, cost effective key starting materials, intermediates and APIs. It intends to build a manufacturing facility with a 230KL capacity in Visakhapatnam, India.
blank
1062580-52-2
Tofacitinib Citrate
Ocimum Labs was founded in 2018 and started its R&D activities with a cutting-edge facility. The Hyd...
Ocimum Labs was founded in 2018 and started its R&D activities with a cutting-edge facility. The Hyderabad-based firm focuses on process research and development, with a particular emphasis on choosing an API portfolio with a wide range of applications for the global pharma market. It provides a wide variety of integrated products and services. By offering timely and high-quality support, Ocimum Labs hopes to become a strategic partner to global pharma firms and deliver high-quality, cost effective key starting materials, intermediates and APIs. It intends to build a manufacturing facility with a 230KL capacity in Visakhapatnam, India.
blank
2008-75-5
Flavoxate
Ocimum Labs was founded in 2018 and started its R&D activities with a cutting-edge facility. The Hyd...
Ocimum Labs was founded in 2018 and started its R&D activities with a cutting-edge facility. The Hyderabad-based firm focuses on process research and development, with a particular emphasis on choosing an API portfolio with a wide range of applications for the global pharma market. It provides a wide variety of integrated products and services. By offering timely and high-quality support, Ocimum Labs hopes to become a strategic partner to global pharma firms and deliver high-quality, cost effective key starting materials, intermediates and APIs. It intends to build a manufacturing facility with a 230KL capacity in Visakhapatnam, India.
blank

05

Fi Europe 2024
Not Confirmed
arrow
Fi Europe 2024
Not Confirmed
arrow

Ocimum Labs

1-(2-Chloroethyl)-piperidine hydrochloride

CAS Number : 2008-75-5

End Use API : Flavoxate

About the Company : Ocimum Labs was founded in 2018 and started its R&D activities with a cutting-edge facility. The Hyderabad-based firm fo...

blank
110963-63-8
Bilastine
Ocimum Labs was founded in 2018 and started its R&D activities with a cutting-edge facility. The Hyd...
Ocimum Labs was founded in 2018 and started its R&D activities with a cutting-edge facility. The Hyderabad-based firm focuses on process research and development, with a particular emphasis on choosing an API portfolio with a wide range of applications for the global pharma market. It provides a wide variety of integrated products and services. By offering timely and high-quality support, Ocimum Labs hopes to become a strategic partner to global pharma firms and deliver high-quality, cost effective key starting materials, intermediates and APIs. It intends to build a manufacturing facility with a 230KL capacity in Visakhapatnam, India.
blank

06

Fi Europe 2024
Not Confirmed
arrow
1841081-72-8
Bilastine
Ocimum Labs was founded in 2018 and started its R&D activities with a cutting-edge facility. The Hyd...
Ocimum Labs was founded in 2018 and started its R&D activities with a cutting-edge facility. The Hyderabad-based firm focuses on process research and development, with a particular emphasis on choosing an API portfolio with a wide range of applications for the global pharma market. It provides a wide variety of integrated products and services. By offering timely and high-quality support, Ocimum Labs hopes to become a strategic partner to global pharma firms and deliver high-quality, cost effective key starting materials, intermediates and APIs. It intends to build a manufacturing facility with a 230KL capacity in Visakhapatnam, India.
blank
1269440-49-4
Encorafenib
Ocimum Labs was founded in 2018 and started its R&D activities with a cutting-edge facility. The Hyd...
Ocimum Labs was founded in 2018 and started its R&D activities with a cutting-edge facility. The Hyderabad-based firm focuses on process research and development, with a particular emphasis on choosing an API portfolio with a wide range of applications for the global pharma market. It provides a wide variety of integrated products and services. By offering timely and high-quality support, Ocimum Labs hopes to become a strategic partner to global pharma firms and deliver high-quality, cost effective key starting materials, intermediates and APIs. It intends to build a manufacturing facility with a 230KL capacity in Visakhapatnam, India.
blank

08

Fi Europe 2024
Not Confirmed
arrow
Fi Europe 2024
Not Confirmed
arrow

Ocimum Labs

1-(3-iodo-1-isopropyl-1H-pyrazol-4-yl)ethanone

CAS Number : 1269440-49-4

End Use API : Encorafenib

About the Company : Ocimum Labs was founded in 2018 and started its R&D activities with a cutting-edge facility. The Hyderabad-based firm fo...

blank
55314-16-4
Imatinib Mesylate
Ocimum Labs was founded in 2018 and started its R&D activities with a cutting-edge facility. The Hyd...
Ocimum Labs was founded in 2018 and started its R&D activities with a cutting-edge facility. The Hyderabad-based firm focuses on process research and development, with a particular emphasis on choosing an API portfolio with a wide range of applications for the global pharma market. It provides a wide variety of integrated products and services. By offering timely and high-quality support, Ocimum Labs hopes to become a strategic partner to global pharma firms and deliver high-quality, cost effective key starting materials, intermediates and APIs. It intends to build a manufacturing facility with a 230KL capacity in Visakhapatnam, India.
blank

09

Fi Europe 2024
Not Confirmed
arrow
17913-18-7
Fluvoxamine
Ocimum Labs was founded in 2018 and started its R&D activities with a cutting-edge facility. The Hyd...
Ocimum Labs was founded in 2018 and started its R&D activities with a cutting-edge facility. The Hyderabad-based firm focuses on process research and development, with a particular emphasis on choosing an API portfolio with a wide range of applications for the global pharma market. It provides a wide variety of integrated products and services. By offering timely and high-quality support, Ocimum Labs hopes to become a strategic partner to global pharma firms and deliver high-quality, cost effective key starting materials, intermediates and APIs. It intends to build a manufacturing facility with a 230KL capacity in Visakhapatnam, India.
blank

10

Fi Europe 2024
Not Confirmed
arrow
Fi Europe 2024
Not Confirmed
arrow

Ocimum Labs

1-chloro-4-methoxybutane

CAS Number : 17913-18-7

End Use API : Fluvoxamine

About the Company : Ocimum Labs was founded in 2018 and started its R&D activities with a cutting-edge facility. The Hyderabad-based firm fo...

blank
Contact Ocimum Labs and get a quotation

Ocimum Labs is a supplier offers 4 products (APIs, Excipients or Intermediates).

Find a price of Bilastine bulk offered by Ocimum Labs

Find a price of Flavoxate bulk offered by Ocimum Labs

Find a price of Lurasidone Hydrochloride bulk offered by Ocimum Labs

Find a price of Ticagrelor bulk offered by Ocimum Labs